Somalogic stock.
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …
Ark Investment Management has been accumulating the stock recently and owns 3.1% of SomaLogic stock. The current market cap of the company is $2.03B and the enterprise value is $1.8B. Over a long ...The stock is currently trading at $2.47 and its $5.06 average price target implies ~105% upside potential by the end of this year. (See BFLY stock forecast ) SomaLogic, Inc. ( SLGC )The current consensus among the four polled investment analysts is to buy stock in Somalogic Inc. This rating has remained steady since January, indicating a consistent positive outlook for the company’s performance. Somalogic Inc reported earnings per share of -$0.13 for the current quarter, suggesting a loss during this period.Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners.
Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Research SomaLogic's (Nasdaq:SLGC) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard …Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...
BOULDER — Biotechnology company SomaLogic Inc. (Nasdaq: SLGC) nearly halved its year-over-year third quarter sales, but still managed to beat Wall Street expectations as it prepares for a $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB). SomaLogic develops platforms to read thousands of proteins in a patient’s ...
Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy …Mar 28, 2023 · SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? SomaLogic, Inc. Warrant (SLGCW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Standard BioTools Inc. and SomaLogic, Inc. is fair to Standard BioTools shareholders. Under the terms of the...
0001837412 false 0001837412 2023-10-04 2023-10-04 0001837412 us-gaap:CommonClassAMem...
Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...
Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, …SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform company. Business combination results in approximately $630 …Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Somalogic Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.30. The median estimate ...Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.
SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …SomaLogic now expects revenue for the full year 2022 of $80.0 to $90.0 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Monday, August 15, 2022 to discuss its second quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and …With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.SomaLogic will host a conference call at 4:30 p.m. ET on Thursday, May 12, 2022, to discuss its first quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at March 31, ...Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …9 oct 2023 ... Mintz is proud to represent Standard BioTools Inc. in its all-stock merger deal with SomaLogic. Our deal team was led by Matthew Gardella, ...
If SomaLogic Opco fails to make the Final Payment as and when due, interest shall thereafter accrue at a rate of 12% per annum until it is paid. Under the terms of the Leases, SomaLogic Opco was required to deliver a letter of credit in the amount of approximately $2,000,000 for each of Lease 1 and Lease 2 to secure the obligations …
Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance …SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in combination ...SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ...Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Oct 4, 2023 · SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ... Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...He currently serves as Chairman of SomaLogic, a company that he founded and formerly served as CEO. ... The most recent stock trade was executed by Asset Management Llp Oxford on 9 October 2019, trading 699,900 units of KBLM stock currently worth $7,355,949.SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.
Nov 27, 2023 · View SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
SomaLogic last released its earnings results on November 8th, 2023. The reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.05. The firm had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic has generated ($0.69) earnings per share over the last year ...
Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ...Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ...Founders David Brunel, Larry Gold. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name SomaLogic, Inc. Stock Symbol FRA:76X0. Company Type For Profit. Contact Email [email protected]. Phone Number 303-625-9000. SomaLogic operates as a protein biomarker discovery and clinical diagnostics company.BOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the …The Company notes that the revised share number in such pro forma tables was determined by multiplying the updated exchange ratio (0.8426) as determined pursuant to the Business Combination Agreement by the number of issued and outstanding shares of SomaLogic common stock prior to consummation of the Business Combination, after …SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.
Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...Instagram:https://instagram. td ameritrade vs tradestationbest fha loanmost cost effective way to buy gold52 wk low Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …SLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) … biolase incwhale stocks SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger. SomaLogic Inc.'s SLGC, -2.54% stock was up about 12% in …According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company. tutor perini corp Nov 30, 2023 · A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Shares of SomaLogic (SLGC-0.35%) ... The healthcare stock is down more than 9% this year. The move was considerable considering the stock was trading at $1.99 a share on Monday, just a penny above ...SomaLogic Inc Class A SLGC Morningstar Rating Stock XNAS Rating as of Nov 21, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...